Curriculum vitae peter J. Quesenberry, M. D



Yüklə 413 Kb.
səhifə1/6
tarix08.08.2018
ölçüsü413 Kb.
#61795
  1   2   3   4   5   6

CURRICULUM VITAE

Peter J. Quesenberry, M.D.
Business Address: Rhode Island Hospital

593 Eddy Street

Providence, Rhode Island 02903
Business Telephone #: (401) 444-4830

Business Fax #: (401) 444-4184

Electronic Mail Address: pquesenberry@lifespan.org
EDUCATION:
Undergraduate: University of Virginia, English, 1960, B.A.

Medical School: University of Virginia, Internal Medicine, 1964, M.D.

Other Advanced Degrees: N/A
POSTGRADUATE TRAINING
Internship: University Hospital, Boston, Massachsuetts, 1964-1965
Residency: Boston City Hospital (B.U. Service), Boston, Massachusetts, Junior and Senior Resident in Medicine, 1967-1969

Fellowship: St. Elizabeth's Hospital, Brighton, Massachusetts, Clinical Hematology Fellow 1969-1970

St. Elizabeth's Hospital, Brighton, Massachusetts, Research Hematology Fellow, 1970-1972

POSTGRADUATE HONORS AND AWARDS
Alpha Omega Alpha (1964)

Raven Society, University of Virginia

IMP Society (1959)

Leukemia Society of America, Kenny Award (1992)

Leukemia Society of America National Leadership Award October (1998)

The Best Doctors in America, Woodward/White, Inc. (1996, 1997, 1998, 1999, 2001)

Leukemia Society Merit Award (1999)

Leukemia Society 50th Anniversary Commemorative Award given to researchers who

are dedicated to finding a cure for leukemia and blood-related cancers and to improving

the quality of life for patients and their families (1999)

Lifetime Achievement Award from Leukemia/Lymphoma Society of America (2006)

Castle Connolly Top Doctors Award (2007)


MILITARY SERVICE:

Medical Officer, USN, 1965-1967

Vietnam/San Francisco

PROFESSIONAL LICENSES AND BOARD CERTIFICATION
Rhode Island, 2001

Massachusetts, 1993

Virginia, 1964

Diplomate in the specialty of Internal Medicine No. 34815, 1971

Diplomate in the subspecialty of Hematology No. 34815, 1972

Diplomate in the subspecialty of Medical Oncology No. 34815, 1975


ACADEMIC APPOINTMENTS
Instructor in Medicine, Tufts Medical School, Boston, Massachusetts, 7/72-6/73

Assistant Professor of Medicine, Tufts Medical School, Boston, Massachusetts, 7/73-6/76

Assistant Professor of Medicine, Harvard Medical School, Boston, Massachusetts, 7/76-6/79

Professor of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, 7/79-12/92

Byrd S. Leavell Professor of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, 7/81-12/92

Professor of Otolaryngology, University of Virginia School of Medicine,

Charlottesville, Virginia, 7/81-12/92

Professor of Medicine, University of Massachusetts Medical Center, Worcester, MA, 1/93-1/00

Interim Chief of Radiation Oncology, University of Massachusetts Medical Center, Worcester, MA, 4/93-11/93

Professor of Cell Biology, University of Massachusetts Medical Center,

Worcester, MA, 2/94-12/00

Graduate School of Biomedical Science, 1994-12/00

Professor of Medicine, Boston University, 1/01-12/00

Professor of Medicine, Brown Medical School, 12/1/06 – present

Paul Calabresi, MD, Professorship in Oncology at The Warren Alpert Medical School of Brown University and Rhode Island Hospital, 12/1/06 - present
HOSPITAL APPOINTMENTS
Chief, Division of Hematology/Oncology, University of Virginia School of Medicine, Charlottesville, Virginia, 7/79-12/92

Director, Cancer Center, University of Massachusetts Medical Center, Worcester, MA, 1/93-1/00

Interim Chief of Radiation Oncology, University of Massachusetts Medical Center, 4/93-11/93

Chair, Dept. of Research, Roger Williams Medical Center, Providence, RI, 1/01 – 9/06

Head, The Center for Stem Cell Biology, Roger Williams Medical Center, Providence, RI, 9/06 – present

Member of Bylaws Committee, Roger Williams Medical Center, Providence, RI, 2002 – 2006

Head, Resource Allocation Committee, Roger Williams Medical Center, Providence, RI, 2002 – 2006

Director, The Adele R. Decof Cancer Center and the Blood and Marrow Transplant Program, Roger Williams Medical Center, Providence, RI, 2004 – September 30, 2006

Director, Division of Hematology/Oncology at Brown Medical School and Lifespan Medical Center, Rhode Island Hospital/Miriam Hospital, October 1, 2006

Executive Director of Hematology/Oncology for Academic Activities at the VA Medical Center and Memorial Hospital of Rhode Island, October 1, 2006

Paul Calabresi, MD, Professorship in Oncology at Brown University/Rhode Island Hospital, October 1, 2006
OTHER APPOINTMENTS
Board of Trustees, Roger Williams Medical Center, 2004-2006

President, International Society for Experimental Hematology (Washington, DC), 7/03-7/04

President-Elect, International Society for Experimental Hematology (Washington, DC), 7/02-7/03

Vice President, International Society for Experimental Hematology (Washington, DC), 7/01-7/02

National Board of Trustees, Leukemia/Lymphoma Society of America, 12/02-12/04

Vice Chairman of the Board, Leukemia/Lymphoma Society of America, 2000 – present

Vice President, Leukemia Society of America, Medical and Scientific Affairs, 1989-1992

Executive Committee, American Society of Hematology, 1985-1988, 1992-1995

Board of Directors, Hospice of Central Massachusetts Visiting Nurses Association, 1995-1996

National Board of Trustees, Leukemia Society of America, 1984-present

President, Southern Society of Clinical Investigation Blood Club, Southern Section, 1984-1985

Board of Directors, American Blood Commission, 1983-1984

American College Of Physicians, MKSAP Hematology Subcommittee, 1983

American Board of Internal Medicine Task Force on Hematology and Medical Oncology, 1983

President, Virginia Society of Hematology, 1982-1983

Board of Trustees, Leukemia Society of America, VA Chapter, 1980-1982


HOSPITAL/UNIVERSITY COMMITTEES
University of Virginia Director, Inpatient Hem/Onc Unit, 1984-1992

Chairman, Committee on the Fluorescent Activated Cell Sorter, 1984

Associate Director for Research and Education of Cancer Center, 1984-1991

Faculty Forum for Scientific Research, 1982

President, Faculty Forum for Scientific Research, 1983

Cancer Committee, 1979-1992

Radiation Safety Committee, 1979-1982

Chief, Hematology/Oncology Clinic, Primary Care Center and Chairman, Institutional Research Grant Committee, American Cancer Society, 1979-1983

University of Mass. Cancer Center Protocol Review Committee, 1995-2000

Chair, Cord Blood Committee, 1995-2000

Graduate Faculty Membership – Graduate School of Biomedical Sciences, 1994-2000

Group Practice Plan Advisory Board, 1994-2000

Clinical Policies Committee, 1994-2000

Chancellor’s Advisory Committee, 1994-2000

Cancer Committee, 1993-2000

Executive Committee, 1993-2000

Executive Council Member, 1993-2000

Roger Williams MC IACUC, 2003-2006

Bylaws Committee, 2002-2004

Resource Allocation Committee, 2002-2006

Cancer Committee, 2005-2006

Cancer Center Leadership Committee, 2004-2006

Research Administration Core Committee, 2001-2006

Strategic Planning Committee, 2003 – 2006

RI Hospital Brown University Dept. Of Medicine Promotions Committee, 2007-present

Cancer Committee, 2006 - present

Education Committee, 2006 - present

Clinical Operations Strategic Committee, 2006 – present

Protocol Office Committee, 2006 - present

Oncology Council, 2007 - 2009

Oncology Council Subgroup, 2007 - 2009

Hematologic Malignancies Symposium Committee, 2007 - 2008

Joint Protocol Committee, 2006 - present

National Vice Chairman of the Board, Leukemia/Lymphoma Society of America, 2000-present

NASA Grant Review, 1998-present

ASH Publications Committee, 1997

Chair, Translational Research Grant Review Committee, LLSA, 1995-present

Patient Aid Committee, 1995-1998

National Heart, Lung, and Blood Institute Program Project Review Committee, 1994-1998

American Society for Blood and Marrow Transplantation, 1994-present

National Bone Marrow Donor Registry Advisory Committee, 2/93-6/94

ACS Scientific Advisory Committee on Chemotherapy and Hematology, 7/92-1993

Association of Hematology and Oncology Program Directors, 1991-1994

ASH, Chairman, Training Grant Committee, 1991

U.S. National Committee for the International Union against Cancer, 7/90-6/94

Vice President, Medical & Scientific Affairs, LLSA, 1989-1992

Ortho Pharmaceuticals Advisory Board, 1988-1992

NHLBI Blood Diseases and Resources Advisory Committee, 1/88-6/91

ASH Growth Factor Educational Session, 1988, 1989, 1991

National Institutes of Health Hematology Study Section, 1/88-6/91

American Society of Hematology, Chairman, Growth Factor Subcommittee, 1988-1989

ASH Erythropoietin and Cell Proliferation Subcommittee, 1988-1989

National Institutes of Health, Chairman, Ad Hoc AIDS Study Section, 1988

Leukemia Society of America – Standard Grant Review Committee, 1986-1994

Chairman, Professional Education Committee, LLSA, 1986-1988

Chairman at Brookhaven National Laboratory, 1985

American College of Physicians Fellow, 1983

Committee on Hematology, American Board of Internal Medicine, 1982-1986

Visiting Committee at Brookhaven National Laboratory, 1982-1986

American Society of Hematology, Chairman, Leukocyte Physiology Subcommittee, 1981

Hematology Study Section, NIH, 1980-1984

ISEH Membership Committee, 1980-1982

National Institute on Arthritis and Metabolic Diseases Subcommittee on Normal Hemopoiesis, 1979-1980

Erythropoietin Distribution Subcommittee, NIH, 1979

American Society of Hematology Scientific Affairs Committee, 1978-1979

Frederick Stohlman, Jr., MD, Memorial Symposium on the Etiology and Treatment of Leukemia, 1974-1979

Scholar, Leukemia Society of America, 1972-1977
MEMBERSHIP IN SOCIETIES
International Society for Cellular Therapy, 2002

American Society of Gene Therapy, 1999

Massachusetts Medical Society, 1997

American Association for the Advancement of Science, 1996

Hospice of Central Massachusetts Visiting Nurses Association, Board of Directors, 1995-96

Southern Society for Clinical Investigation, 1993

Vice President, Medical & Scientific Affairs, LLSA, 1989-92

President, Southern Society of Clinical Investigation Blood Club, Southern Section, 1984-1985

American Clinical & Climatologic Association, 1984

American Society of Clinical Oncology, 1981

American Society of Clinical Investigation, 1981

Virginia Society of Hematology, 1980-1992

American Association for Cancer Research

American College of Physicians, MKSAP Hematology Subcommittee, American Board of Internal Medicine Task Force on Hematology and Medical Oncology, 1983

American Blood Commission, Board of Directors, 1981

American Federation for Medical Research

American Medical Association

American Society for Blood and Marrow Transplantation, 1994

American Society of Hematology, 1978

International Society for Cellular Therapy, 2002

International Society for Experimental Hematology

Rhode Island Medical Society, 2003

Society for Neuroscience

Leukemia Society of America, Vice President, Board of Trustees, Virginia Chapter, Virginia Society of Hematology, 1980-1992


ORIGINAL PUBLICATIONS IN PEER-REVIEWED JOURNALS


  1. Morley A, Rickard KA, Quesenberry PJ, Garrity M, Stohlman F Jr: Studies on the regulation of granulopoiesis. V. Effect of marrow cells on colony stimulating activity in serum. J Cell Physiol 77:301-304, 1971.




  1. Morley A, Quesenberry PJ, Garrity M, Stohlman F Jr: Inhibition of marrow growth by cyclic AMP. Proc Soc Exp Biol Med 138:57-59, 1971.




  1. Quesenberry PJ, Morley A, Stohlman F Jr, Rickard K, Howard D, Smith M: Effect of endotoxin on granulopoiesis and colony-stimulating factor. N Engl J Med 286:227-232, 1972.




  1. Morley A, Quesenberry PJ, Bealmear P, Stohlman F Jr, Wilson R: Serum colony stimulating factor levels in irradiated germfree and conventional GFW mice. Proc Soc Exp Biol Med 140:478-480, 1972.




  1. Stohlman F Jr, Quesenberry PJ: Colony-stimulating factor and myelopoiesis. Blood 39(5):727-732, 1972.




  1. Quesenberry PJ, Morley A, Miller M, Rickard K, Howard D, Stohlman F Jr: Effect of endotoxin on granulopoiesis and the in vitro colony-forming cell. Blood 41(3):391-398, 1973.




  1. Niskanen E, Quesenberry PJ, Stohlman Jr F, Levin J, Ryan M: Colony stimulating and inhibiting factors in sera from normal and endotoxin treated CF1 mice. Proc Soc Exp Biol Med 143:176-180, 1973.




  1. Quesenberry PJ, Morley A, Ryan M, Howard D, Stohlman F Jr: The effect of endotoxin on murine stem cells. J Cell Physiol 82(2):239-244, 1973.




  1. Quesenberry PJ, Niskanen E, Symann M, Howard D, Ryan M, Halpern J, Stohlman F Jr: Growth of stem cell concentrates in diffusion chambers. Cell Tissue Kinet 7:337-348, 1974.




  1. Quesenberry PJ, Bealmear P, Ryan M, Stohlman F Jr: Serum colony stimulating and inhibiting factors in irradiated germfree and conventional mice. Br J Haematol 28:531-539, 1974.




  1. Quesenberry PJ, Halperin J, Ryan M, Stohlman F Jr: Tolerance to the granulocyte-releasing and colony-stimulating factor elevating effects of endotoxin. Blood 45(6):789-800, 1975.




  1. Symann M, Fontebuoni A, Quesenberry PJ, Howard D, Stohlman F Jr: Fetal hemopoiesis in diffusion chamber cultures. I. The pattern of pluripotent stem cell growth. Cell Tissue Kinet 9(1):41-49, 1976.




  1. Symann M, Quesenberry PJ, Fontebuoni A, Stohlman F Jr: Fetal hemopoiesis in diffusion chamber cultures: II. Cell proliferation and differentiation. Nouv Rev Fr Hematol 16(3):321-328, 1976.




  1. Symann M, Quesenberry PJ, Fontebuoni A, Howard D, Ryan M, Stohlman F Jr: Fetal hemopoiesis in diffusion chamber cultures: III. The effect of neutropenia. Blood 48(2):283-291, 1976.




  1. Camitta BM, Quesenberry PJ, Parkman R, Boxer LA, Stossel TP, Cassady JR, Rappeport JM, Nathan DG: Bone marrow transplantation for an infant with neutrophil dysfunction. Exp Hematol 5(2):109-116, 1977.




  1. Quesenberry PJ, Zuckerman K, Ryan M, Stohlman F Jr: Dichotomy between the release of bone marrow granulocytes and stem cells. Proc Soc Exp Biol Med 154(1):53-56, 1977.




  1. Quesenberry PJ, Cohen H, Levin J, Sullivan R, Bealmear P, Ryan M: Effects of bacterial infection and irradiation on serum colony-stimulating factor levels in tolerant and non-tolerant CF1 mice. Blood 51(2):229-244, 1978.




  1. Zuckerman KS, Sullivan R, Quesenberry PJ: Effects of actinomycin D in vivo on murine erythroid stem cells. Blood 51(5):957-969, 1978.




  1. Quesenberry PJ, Rappeport JM, Fountebuoni A, Sullivan R, Zuckerman K, Ryan M: Inhibition of normal murine hematopoiesis by leukemic cells. N Engl J Med 299(2):71-75, 1978.




  1. Quesenberry PJ, Levin J, Zuckerman K, Rencricca N, Sullivan R, Tyler W: Stem cell migration induced by erythropoietin or haemolytic anaemia: The effects of actinomycin and endotoxin contamination of erythropoietin preparations. Br J Haematol 41(2):253-269, 1979.




  1. Zuckerman KS, Quesenberry PJ, Levin J, Sullivan R: Contamination of erythropoietin by endotoxin: In vivo and in vitro effects on murine erythropoiesis. Blood 54(1):146-158, 1979.




  1. Quesenberry PJ, Levitt L, Monette F, Eichacker PQ, Zuckerman KS, Sullivan R, Ryan M: The use of stem cell assays to monitor the proliferative potential of bone marrow cells. Exp Hematol 7 Suppl 5:210-227, 1979.




  1. Sullivan R, Zuckerman KS, Quesenberry PJ: The role of colony stimulating activity in modulating murine diffusion chamber granulopoiesis. Bri J Haematol 44(3):365-374, 1980.




  1. Quesenberry PJ, Gimbrone M, Niskanen E, Levitt L, Coppola M, D'Amore P, Ryan M: Further studies on the development of tolerance to the colony stimulating activity-inducing properties of endotoxin. J Am Soc Microbiol 13:121-124, 1980.




  1. Levitt LJ, Quesenberry PJ: The effect of lithium on murine hematopoiesis in a liquid culture system. N Engl J Med 302(13):713-719, 1980.




  1. Sullivan R, Quesenberry PJ, Parkman R, Zuckerman KS, Rappeport J, Levey RH, Ryan M: Aplastic anemia: Lack of inhibitory effect of bone marrow lymphocytes on in vitro granulopoiesis. Blood 56(4):625-632, 1980.




  1. Quesenberry PJ, Gimbrone MA Jr: Vascular endothelium as a regulator of granulopoiesis: Production of colony-stimulating activity by cultured human endothelial cells. Blood 56(6):1060-1067, 1980.




  1. Quesenberry PJ, Stanley K: A statistical analysis of murine stem cell suicide techniques. Blood 56(6):1000-1005, 1980.




  1. Symann M, Anckaert M, Quesenberry PJ, Fountebuoni A, Rodhain J, Chatelain: Hematopoietic growth factors. In: Intl J Cell Cloning, Vol. 4, pp. 3-15, 1980.




  1. Levitt LJ, Quesenberry PJ, Monette FC, Zuckerman K, Sullivan R, Ryan M: Utilization of mouse stem cell-depleted marrow in the study of diffusion chamber myelopoiesis. Proc Soc Exp Biol Med 167(2):188-193, 1981.




  1. Niskanen EO, Wells JR, Quesenberry PJ, Cline MJ: Effect of cryopreservation on recovery of cells forming colonies in diffusion chambers in mice (CFUD). Exp Hematol 9(4):411-414, 1981.




  1. Levitt LJ, Quesenberry PJ: Further studies on the mechanism of marrow granulocytic hyperplasia in mice chronically injected with endotoxin. Br J Haematol 50(2):269-281, 1982.




  1. Thorner MO, Borges JL, Cronin MJ, Keefer DA, Hellmann P, Lewis D, Dabney LG, Quesenberry PJ: Fluorescence activated cell sorting of functional anterior pituitary cells. Endocrinology 110(5):1831-1833, 1982.




  1. Boswell HS, Niskanen EO, Coppola MA, Quesenberry PJ: Cryopreservation of marrow and stromal progenitor cells: Use of long-term liquid culture as a measure of the recovery of renewable hematopoietic and stromal cells. Exp Hematol 11(4):315-323, 1983.




  1. Quesenberry PJ, Coppola MA, Gualtieri RJ, Wade PM, Song Z, Doukas MA, Shideler CE, Baker DG, McGrath EH: Lithium stimulation of murine hematopoiesis in liquid culture: An effect mediated by marrow stromal cells. Blood 63(1):121-127, 1984.




  1. Gualtieri RJ, Shadduck RK, Baker DG, Quesenberry PJ: Hematopoietic regulatory factors produced in long-term murine bone marrow cultures and the effect of in vitro irradiation. Blood 64(2):516-525, 1984.




  1. Song ZX, Quesenberry PJ: Radioresistant murine marrow stromal cells: A morphologic and functional characterization. Exp Hematol 12(7):523-533, 1984.




  1. Boswell HS, Wade PM Jr, Quesenberry PJ: Thy-1 antigen expression by murine high-proliferative capacity hematopoietic progenitor cells: Relation between sensitivity to depletion by Thy-1 antibody and stem cell generation potential. J Immunol 133(6):2940-2949, 1984.




  1. Doukas MA, Niskanen EO, Quesenberry PJ: Lithium stimulation of granulopoiesis in diffusion chambers--a model of humoral, indirect stimulation of stem cell proliferation. Blood 65(1):163-168, 1985.




  1. Quesenberry PJ, Ihle JN, McGrath E: The effect of interleukin-3 and GM-CSA-2 on megakaryocyte and myeloid clonal colony formation. Blood 65(1):214-217, 1985.




  1. Quesenberry PJ, Alberico T, Song ZX, Donowitz G, Stewart FM, Gualtieri R, Boswell S, McGrath E, Kleeman E, Baber G, Cranston S: Studies on the regulation of hemopoiesis. Exp Hematol 13 Suppl 16:43-48, 1985.




  1. Song ZX, Shadduck RK, Innes DJ Jr, Waheed A, Quesenberry PJ: Hematopoietic factor production by a cell line (TC-1) derived from adherent murine marrow cells. Blood 66(2):273-281, 1985.




  1. Louie EK, Ault KA, Smith BR, Hardman EL, Quesenberry PJ: IgG-mediated haemolysis masquerading as cold agglutinin-induced anaemia complicating severe infection with mycoplasma pneumoniae. Scand J Haematol 35(3):264-269, 1985.




  1. Waterhouse EJ, Quesenberry PJ, Balian G: Collagen synthesis by murine bone marrow cell culture. J Cell Physiol 127(3):397-402, 1986.




  1. Luedke DW, Luedke SL, Martelo O, Quesenberry PJ, Birch R, Schlueter J, Hake J, Logan T: Vindesine and mitomycin in the treatment of advanced non-small cell lung cancer: A Southeastern Cancer Study Group Trial. Cancer Treat Rep 70(5):651-653, 1986.




  1. Donowitz G, Quesenberry PJ: 5-Fluorouracil effect on cultured murine stem cell progeny and peripheral leukocytes. Exp Hematol 14:207-214, 1986.




  1. Gualtieri RJ, Berne RM, McGrath HE, Huster WJ, Quesenberry PJ: Effect of adenine nucleotides on granulopoiesis and lithium-induced granulocytosis in long-term bone marrow cultures. Exp Hematol 14(7):689-695, 1986.




  1. Doukas MA, Niskanen E, Quesenberry PJ: Effect of lithium on stem cell and stromal cell proliferation in vitro. Exp Hematol 14(3):215-221, 1986.




  1. Quesenberry PJ, Song ZX, McGrath E, McNiece I, Shadduck R, Waheed A, Baber G, Kleeman E, Kaiser D: Multilineage synergistic activity produced by a murine adherent marrow cell line. Blood 69(3):827-835, 1987.




  1. Alberico TA, Ihle JN, McGrath HE, Liang CM, Quesenberry PJ: Stromal growth factor production in irradiated lectin exposed long-term murine bone marrow cultures. Blood 69(4):1120-1127, 1987.




  1. Robinson BE, McGrath HE, Quesenberry PJ: Recombinant murine granulocyte macrophage colony-stimulating factor has megakaryocyte colony-stimulating activity and augments megakaryocyte colony stimulation by interleukin-3. J Clin Invest 79(6):1648-1652, 1987.




  1. Colon-Otero G, Sando JJ, Sims JL, McGrath E, Jensen DE, Quesenberry PJ: Inhibition of hemopoietic growth factor-induced proliferation by adenosine diphosphate-ribosylation inhibitors. Blood 70(3):686-693, 1987.




  1. McGrath HE, Liang CM, Alberico TA, Quesenberry PJ: The effect of lithium on growth factor production in long-term bone marrow cultures. Blood 70(4):1136-1142, 1987.




  1. He YX, Hewlett E, Temeles D, Quesenberry PJ: Inhibition of interleukin-3 and colony-stimulating factor 1-stimulated marrow cell proliferation by pertussis toxin. Blood 71(5):1187-1195, 1988.




  1. Song ZX, Thomas C, Innes D, Waheed A, Shadduck RK, Quesenberry PJ: Characterization of two clones isolated from the TC-1 murine marrow stromal cell line: Growth factor and retrovirus production and physical support of hemopoiesis. Int J Cell Cloning 6(2):125-145, 1988.




  1. McNiece IK, Stewart FM, Deacon DH, Quesenberry PJ: Synergistic interactions between hematopoietic growth factors as detected by in vitro mouse bone marrow colony formation. Exp Hematol 16(5):383-388, 1988.




  1. McNiece IK, Robinson BE, Quesenberry PJ: Stimulation of murine colony-forming cells with high proliferative potential by the combination of GM-CSF and CSF-1. Blood 72(1):191-195, 1988.




  1. McNiece IK, McGrath HE, Quesenberry PJ: Granulocyte colony-stimulating factor augments in vitro megakaryocyte colony formation by interleukin-3. Exp Hematol 16(9):807-810, 1988.




  1. McNiece IK, Kriegler AB, Quesenberry PJ: Studies on the myeloid synergistic factor from 5637: Comparison with interleukin-1 alpha. Blood 73(4):919-923, 1989.




  1. Tabbara IA, Quesenberry PJ, Hahn SS, Stewart FM: Treatment of small cell carcinoma with weekly combination chemotherapy: A pilot study. Anticancer Res 9(1):189-192, 1989.




  1. McNiece IK, Andrews R, Stewart M, Clark S, Boone T, Quesenberry PJ: Action of interleukin-3, G-CSF, and GM-CSF on highly enriched human hematopoietic progenitor cells: Synergistic interaction of GM-CSF plus G-CSF. Blood 74(1):110-114, 1989.




  1. Simpson L, McNiece I, Newberg M, Schetz J, Lynch KR, Quesenberry PJ, Isakson PC: Detection and characterization of a B cell stimulatory factor (BSF-TC) derived from a bone marrow stromal cell line. J Immunol 142(11):3894-3900, 1989.




  1. McNiece IK, Stewart FM, Deacon DM, Temeles DS, Zsebo KM, Clark SC, Quesenberry PJ: Detection of a human CFC with a high proliferative potential. Blood 74(2):609-612, 1989.




  1. Tabbara IA, Sibley DS, Quesenberry PJ: Spinal cord compression due to metastatic neoplasm. South Med J 83(5):519-523, 1990.




  1. Keller JR, McNiece IK, Sill KT, Ellingsworth LR, Quesenberry PJ, Sing GK, Ruscetti FW: Transforming growth factor beta directly regulates primitive murine hematopoietic cell proliferation. Blood 75(3):596-602, 1990.




  1. Niskanen E, Quesenberry PJ, Shellem TA, McNiece I: Relationship between cells forming colonies in diffusion chambers in vivo (CFU-D) and cells with high proliferative potential in vitro (HPP-CFC-1&-2). Exp Hematol 18(4):294-298, 1990.




  1. Woodward TA, McNiece IK, Witte PL, Bender P, Crittenden R, Temeles DS, Robinson BE, Baber GB, Deacon DH, Isakson PC, Quesenberry PJ: Further studies on growth factor production by the TC-1 stromal cell line: Pre-B stimulating activity. Blood 75:2130-2136, 1990.




  1. Ruland LJ 3rd, Quesenberry PJ, Balian G: A 17-kd polypeptide, sensitive to bacterial collagenase, is synthesized by bone marrow macrophages. Exp Hematol 18(9):969-973, 1990.




  1. Hussaini IM, Srikumar K, Quesenberry PJ, Gonias SL: Colony-stimulating factor-1 modulates alpha 2-macroglobulin receptor expression in murine bone marrow macrophages. J Biol Chem 265(32):19441-19446, 1990.




  1. Quesenberry PJ, McGrath HE, Williams ME, Robinson BE, Deacon DH, Clark S, Urdal D, McNiece IK: Multifactor stimulation of megakaryocytopoiesis: Effects of Interleukin-6. Exp Hematol 19(1):35-41, 1991.




  1. Lowry PA, Zsebo KM, Deacon DH, Eichman CE, Quesenberry PJ: Effects of rrSCF on multiple cytokine responsive HPP-CFC generated from SCA+Lin- murine hematopoietic progenitors. Exp Hematol 19(9):994-996, 1991.




  1. Kittler EL, McGrath H, Temeles D, Crittenden RB, Kister VK, Quesenberry PJ: Biologic significance of constitutive and subliminal growth factor production by bone marrow stroma. Blood 79(12):3168-3178, 1992.




  1. Quesenberry PJ: Parma. Exp Hematol 20(5):535-9, 1992.




  1. McGrath HE, Wade PM, Kister VK, Quesenberry PJ: Lithium stimulation of HPP-CFC and stromal growth factor production in murine Dexter culture. J Cell Physiol 151(2):276-286, 1992.




  1. Reddy GP, Reed WC, Deacon DH, Quesenberry PJ: Growth factor-dependent proliferative stimulation of hematopoietic cells is associated with the modulation of cytoplasmic and nuclear 68-Kd calmodulin-binding protein. Blood 79(8):1946-1955, 1992.




  1. Lowry PA, Deacon D, Whitefield P, McGrath HE, Quesenberry PJ: Stem Cell Factor induction of in vitro murine hematopoietic colony formation by "subliminal" cytokine combinations: The role of "anchor factors". Blood 80(3):663-669, 1992.




  1. Temeles DS, McGrath HE, Kittler EL, Shadduck RK, Kister VK, Crittenden RB, Turner BL, Quesenberry PJ: Cytokine expression from bone marrow derived macrophages. Exp Hematol 21(2):388-393, 1993.




  1. Stewart FM, Crittenden RB, Lowry PA, Pearson-White S, Quesenberry PJ: Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice. Blood 81(10):2566-2571, 1993.




  1. Stewart FM, Temeles D, Lowry P, Thraves T, Grosh WW, Quesenberry PJ: Post-5-fluorouracil human marrow: Stem cell characteristics and renewal properties after autologous marrow transplantation. Blood 81(9):2283-2289, 1993.




  1. Gomez RA, Norling LL, Wilfong N, Isakson P, Lynch KR, Hock R, Quesenberry PJ: Leukocytes synthesize angiotensinogen. Hypertension 21(4):470-475, 1993.




  1. LaMarre J, Wolf BB, Kittler EL, Quesenberry PJ, Gonias SL: Regulation of macrophage alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein by lipopolysaccharide and interferon-gamma. J Clin Invest 91(3):1219-24, 1993.




  1. Weich NS, Tullai J, Guido E, McMahon M, Jolliffe LK, Lopez AF, Vadas MA, Lowry PA, Quesenberry PJ, Rosen J: Interleukin-3/Erythropoietin fusion proteins: In vitro effects on hematopoietic cells. Exp Hematol 21(5):647-655, 1993.




  1. Reddy GP, Reed WC, Deacon DH, Quesenberry PJ: Growth factor modulated calmodulin-binding protein stimulates nuclear DNA synthesis in hemopoietic progenitor cells. Biochemistry 33(21):6605-6610, 1994.




  1. Quesenberry PJ, Ramshaw H, Crittenden RB, Stewart FM, Rao SS, Peters S, Becker P, Lowry P, Blomberg M, Reilly J, Tiarks C: Engraftment of normal murine marrow into non-myeloablated host mice. Blood Cells 20(2-3):348-350, 1994.




  1. Quesenberry PJ, Ramshaw HS, Rao S, Peters S, Blomberg M, Kittler ELW, Lowry P, Stewart FM, Tiarks C, Reilly J, Crittenden R: Repetitive marrow transplantation into nonmyeloablated hosts. Blood Cells 20:348-350, 1994.




  1. Cao QP, McGrath CA, Baril EF, Quesenberry PJ, Reddy GP: The 68 kDa calmodulin-binding protein is tightly associated with the multiprotein DNA polymerase alpha-primase complex in HeLa cells. Biochemistry 34(12):3878-3883, 1995.



  1. Shakoori R, van Wijnen AJ, Cooper C, Aziz F, Birnbaum M, Reddy GPV, DeLuca A, Grana X, Giordano A, Lian JB, Stein JL, Quesenberry PJ, Stein GS: Cytokine induction of proliferation and expression of CDC2 and cyclin A in FDC-P1 myeloid hematopoietic progenitor cells: Regulation of ubiquitous and cell cycle-dependent histone gene transcription factors. J Cell Biochem. 58:1-12, 1995.




  1. Peters SO, Kittler EL, Ramshaw HS, Quesenberry PJ: Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts. Exp Hematol 23(5):461-469, 1995.




  1. Ramshaw HS, Rao SS, Crittenden RB, Peters SO, Weier HU, Quesenberry PJ: Engraftment of bone marrow cells into normal unprepared hosts: Effects of 5-fluorouracil and cell cycle status. Blood 86(3):924-929, 1995.




  1. Pearson-White S, Deacon D, Crittenden R, Brady G, Iscove N, Quesenberry PJ: The ski/sno protooncogene family in hematopoietic development. Blood 86(6):2146-2155, 1995.




  1. Lowry PA, Deacon DM, Whitefield P, Rao S, Quesenberry M, Quesenberry PJ: The high-proliferative-potential megakaryocyte mixed (HPP-Meg-Mix) cell: A trilineage murine hematopoietic progenitor with multiple growth factor responsiveness. Exp Hematol 23(10):1135-1140, 1995.




  1. Stein GS, Stein JL, van Wijnen A, Lian JB, Quesenberry PJ: Molecular mechanisms mediating control of cell cycle and cell growth. Exp Hematol. 23(10):1053-1061, 1995.




  1. Kittler EL, Quesenberry PJ: Concept and organization of a clinical gene therapy lab. J Cell Biochem 58:403-409, 1995.




  1. Shakoori AR, van Wijnen AJ, Cooper C, Aziz F, Birnbaum M, Reddy GPV, Grana X, De Luca A, Giordano A Lian JB, Stein JL, Quesenberry PJ, Stein GS: Cytokine induction of proliferation and expression of CDC2 and cyclin A in FDC-P1 myeloid hematopoietic progenitor cells: Regulation of ubiquitous and cell cycle-dependent histone gene transcription factors. J Cell Biochem 59:291-302, 1995.




  1. Ramshaw HS, Crittenden RB, Dooner M, Peters SO, Rao SS, Quesenberry PJ: High levels of engraftment with a single infusion of bone marrow cells into normal unprepared mice. Biol Blood Marrow Transplant 1(2):74-80, 1995.




  1. Peters SO, Kittler EL, Ramshaw HS, Quesenberry PJ: Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 87(1):30-37, 1996.




  1. Knecht H, Raphaël M, McQuain C, Rothenberger S, Pihan G, Camilleri-Broët S, Bachmann E, Kershaw GR, Ryan S, Kittler EL, Quesenberry PJ, Schlaifer D, Woda BA, Brousset P: Deletion variants within the NF-kappa B activation domain of the LMP1 oncogene prevail in Acquired Immunodeficiency Syndrome-related large cell lymphomas and Human Immunodeficiency Virus-negative atypical lymphoproliferations. Blood 87(3):876-881, 1996.




  1. Reddy GP, Quesenberry PJ: Stem Cell Factor enhances Interleukin-3-dependent induction of 68-kD calmodulin-binding protein and thymidine kinase activity in NFS-60 cells. Blood 87(8):3195-3202, 1996.




  1. Quesenberry PJ, Iscove NN, Cooper C, Brady G, Newburger PE, Stein GS, Stein JS, Reddy GP, Pearson-White S: Expression of basic helix-loop-helix transcription factors in explant hematopoietic progenitors. J Cell Biochem 61(3):478-488, 1996.




  1. Lowry PA, Shultz LD, Greiner DL, Hesselton RM, Kittler EL, Tiarks CY, Rao SS, Reilly J, Leif JH, Ramshaw HS, Stewart FM, Quesenberry PJ: Improved engraftment of human cord blood stem cells in NOD/LtSz-scid/scid mice after irradiation or multiple-day injections into unirradiated recipients. Biol Blood Marrow Transplant 2(1):15-23, 1996.




  1. Knecht H, McQuain C, Rothenberger S, Drexler HG, Martin J, Berger C, Bachmann E, Kittler EL, Odermatt BF, Quesenberry PJ: Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology. Oncogene, 13(5):947-953, 1996.




  1. Nilsson SK, Hulspas R, Weier HU, Quesenberry PJ: In situ detection of individual transplanted bone marrow cells using FISH on sections of paraffin-embedded whole murine femurs. J Histochem Cytochem 44(9):1069-1074, 1996.




  1. Rao SS, Peters SO, Crittenden RB, Stewart FM, Ramshaw HS, Quesenberry PJ: Stem cell transplantation in the normal nonmyeloablated host: Relationship between cell dose, schedule, and engraftment. Exp Hematol 25(2):114-121, 1997.




  1. Larcher C, McQuain C, Berger C, Mitterer M, Quesenberry PJ, Huemer HP, Knecht H: Epstein-Barr virus-associated persistent polyclonal B-cell lymphocytosis with a distinct 69-base pair deletion in the LMP1 oncogene. Ann Hematol 74(1):23-28, 1997.




  1. Lachyankar MB, Condon PJ, Quesenberry PJ, Litofsky NS, Recht LD, Ross, AH: Embryonic precursor cells that express Trk Receptors: Induction of different cell fates by NGF, BDNF, NT-3, and CNTF. Exp Neurol 144(2):350-360, 1997.




  1. Lachyankar MB, Ross AH, Litofsky NS, Condon PJ, Quesenberry PJ, Recht LD: TrkA Expression decreases the in vivo aggressiveness of C6 Glioma Cells. Cancer Res. 57(3):532-536, 1997.




  1. Cooper CL, Brady G, Bilia F, Iscove NN, Quesenberry PJ: Expression of the Id family helix-loop-helix regulators during growth and development in the hematopoietic system. Blood 89(9):3155-3165, 1997.




  1. Nilsson SK, Dooner MS, Tiarks CY, Weier HU, Quesenberry PJ: Potential and distribution of transplanted hematopoietic stem cells in a nonablated mouse model. Blood 89(11):4013-4020, 1997.




  1. Kittler EL, Peters SO, Crittenden RB, Debatis ME, Ramshaw HS, Stewart FM, Quesenberry PJ: Cytokine-Facilitated Transduction Leads to Low-Level Engraftment in Nonablated Hosts. Blood 90(2):865-872, 1997.




  1. Reddy GP, Tiarks CY, Pang L, Wuu J, Hsieh CC, Quesenberry PJ: Cell cycle analysis and synchronization of pluripotent hematopoietic progenitor stem cells. Blood 90(6):2293-2299, 1997.




  1. Kershaw GR, Berger C, McQuain C, Al-Homsi AS, Pihan G, Quesenberry PJ, Woda BA, Knecht H: Selective outgrowth of a post-transplant B-immunoblastic lymphoma expressing a Latent Membrane Protein-1 deletion variant. Transplantation 64(7):1079-1081, 1997.




  1. Hulspas R, Tiarks C, Reilly J, Hsieh C, Recht L, Quesenberry PJ: In Vitro Cell Density- Dependent Clonal Growth of EGF-Responsive Murine Neural Progenitor Cells under Serum-free Conditions. Exp Neurol 148(1):147-156, 1997.




  1. van Wijnen AJ, Cooper C, Odgren P, Aziz F, De Luca A, Shakoori RA, Giordano A, Quesenberry PJ, Lian JB, Stein GS, Stein JL: Cell cycle-dependent modifications in activities of pRb-related tumor suppressors and proliferation-specific CDP/cut homeodomain factors in murine hematopoietic progenitor cells. J Cell Biochem. 66(4):512-523, 1997.




  1. Nilsson SK, Dooner MS, Quesenberry PJ: Synchronized Cell-Cycle Induction of Engrafting Long-Term Repopulating Stem Cells. Blood 90(11):4646-4650, 1997.




  1. Berger C, McQuain C, Sullivan JL, Nadal D, Quesenberry PJ, Knecht H: The 30-bp Deletion Variant Of Epstein-Barr Virus-Encoded Latent Membrane Protein-1 Prevails In Acute Infectious Mononucleosis. J Infect Dis 176(5):1370-1373, 1997.




  1. Nilsson SK, Debatis ME, Dooner MS, Madri JA, Quesenberry PJ, Becker PS: Immunofluorescence Characterization of Key Extracellular Matrix Proteins in Murine Bone Marrow In Situ. J Histochem Cytochem 46(3):371-377, 1998.




  1. Blomberg M, Rao S, Reilly J, Tiarks C, Peters S, Kittler E, Quesenberry PJ: Repetitive Bone Marrow Transplantation in Nonmyeloablated Recipients. Exp Hematol 26(4):320-324, 1998.




  1. Savarese DMF, Valinski H, Quesenberry PJ, Savarese, T: Expression and function of colony-stimulating factors and their receptors in human prostate carcinoma cell lines. Prostate 34:80-91, 1998.




  1. Stewart FM, Zhong S, Wuu J, Hsieh CC, Nilsson SK, Quesenberry PJ: Lymphohematopoietic engraftment in minimally myeloablated hosts. Blood, 91(10):3681-3687, 1998.




  1. Ballen KK, Hsieh CC, Levy W, Becker PS, Lee K, Butler K, Lefebvre K, Quesenbery PJ, Stewart FM: Coverage of bone marrow transplant patients: A survey of American and Canadian Institutions. Biology of Blood & Marrow Transplantation. 4:49-55, 1998.




  1. Quesenberry PJ, Stewart FM, Habibian H, McAuliffe C, Reilly J, Carlson J, Dooner M, Nilsson S, Peters S, Becker P: Lymphohematopoietic Stem Cell Engraftment. Proceedings of the Hematopoietic Stem Cells II, International Symposium and Workshop. University of Tubingen, Meersburg, Germany. Annals of NY Acad of Sci, Pgs. 40-47, 1998.




  1. Patchen ML, Liang J, Vaudrain T, Martin T, Melican D, Zhong S, Stewart M, Quesenberry PJ: Mobilization of Peripheral Blood Progenitor Cells by Betafectin® PGG-Glucan Alone and in Combination with Granulocyte Colony-Stimulating Factor. Stem Cells 16(3):208-217, 1998.




  1. Habibian HK, Peters SO, Hsieh CC, Wuu J, Vergilis K, Grimaldi CI, Reilly J, Carlson JE, Frimberger AE, Stewart FM, Quesenberry PJ: The Fluctuating Phenotype of the Lymphohematopoietic Stem Cell with Cell Cycle Transit. J Exp Med 188(2):393-398, 1998.




  1. Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry PJ, Doxsey SJ: Centrosome defects and genetic instability in malignant tumors. Cancer Res. 58(17):3974-3985, 1998.




  1. Nilsson SK, Dooner MS, Weier HU, Frenkel B, Lian JB, Stein GS, Quesenberry PJ: Cells capable of bone production engraft from whole bone marrow transplants in nonablated mice. J Exp Med 189(4):729-734, 1999.




  1. Campbell CL, Savarese DM, Quesenberry PJ, Savarese TM: Expression of multiple angiogenic cytokines in cultured normal human prostate epithelial cells: predominance of vascular endothelial growth factor. Int J Cancer 80(6):868-874, 1999.




  1. Becker PS, Nilsson SK, Li Z, Berrios VM, Dooner MS, Cooper CL, Hsieh CC, Quesenberry PJ: Adhesion receptor expression by hematopoietic cell lines and murine progenitors: Modulation by cytokines and cell cycle status. Exp Hematol 27(3):533-541, 1999.




  1. Hou Z, Nguyen Q, Frenkel B, Nilsson SK, Milne M, van Wijnen AJ, Stein JL, Quesenberry PJ, Lian JB, Stein GS: Osteoblast-specific gene expression after transplantation of marrow cells: Implications for skeletal gene therapy. Proc Natl Acad Sci 96(13):7294-7299, 1999.




  1. Peters SO, Habibian HK, Vergilis K, Quesenberry PJ: Effects of cytokines on stem cell engraftment depends on time of evaluation post-marrow infusion. Int J Hematol 70(2):112-118, 1999.




  1. Knecht H, Berger C, McQuain C, Rothenberger S, Bachmann E, Martin J, Esslinger C, Drexler HG, Cai YC, Quesenberry PJ, Odermatt BF: Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin’s disease. Oncogene 18(50):7161-7167, 1999.




  1. Quesenberry PJ: Engraftment of Lymphohematopoietic Stem Cells. Proceedings from the Immuno Conference, 1999.




  1. Ballen K, Becker P, Lefebvre K, Emmons R, Lee K, Levy W, Stewart FM, Quesenberry PJ, Lowry P: Safety and cost of hyperhydration for the prevention of hemorrhagic cystitis in bone marrow transplant recipients. Oncology 57:287-292, 1999.




  1. Ballen K, Becker PS, Greiner D, Valinski H, Shearin D, Berrios V, Dooner G, Hsieh CC, Wuu J, Shultz L, Cerny J, Leif J, Stewart FM, Quesenberry PJ: Effect of ex vivo cytokine treatment on human cord blood engraftment in NOD-scid mice. Br J Haemotol 108(3):629-640, 2000.




  1. Hulspas R, Quesenberry PJ: Characterization of neurosphere cell phenotypes by flow cytometry. Cytometry 40(3):245-250, 2000.




  1. Lachyankar MB, Sultana N, Schonhoff CM, Mitra P, Poluha W, Lambert S, Quesenberry PJ, Litofsky NS, Nabi R, Recht LD, Miller SJ, Ohta S, Neel BG, Ross AH: A role for nuclear PTEN in neuronal differentiation. J Neurosci 20(4):1404 -1413, 2000.




  1. Lambert JF, Benoit BO, Colvin GA, Carlson J, Delville Y, Quesenberry PJ: Quick sex determination of mouse fetuses. J Neurosci Methods 95(2):127-132, 2000.




  1. Gordon JA, Pockwinse SM, Stewart FM, Quesenberry PJ, Nakamura T, Croce CM, Lian JB, Stein JL, van Wijnen AJ, Stein GS: Modified Intranuclear Organization of Regulatory Factors in Human Acute Leukemias: Reversal After Treatment. J Cell Biochem 77(1):30-43, 2000.




  1. Ballen KK, Ford PA, Waitkus H, Emmons RVB, Levy W, Doyle P, Stewart FM, Quesenberry PJ, Becker PS: Successful autologous bone marrow transplant without the use of blood product support. Bone Marrow Transplant 26(2):227-229, 2000.




  1. Savarese TM, Mitchell, K, McQuain C, Campbell CL, Guardiani R, Wuu J, Ollari C, Reale F, Chen A, Nelson BE, Quesenberry PJ: Coexpression of granulocyte colony stimulating factor and its receptor in primary ovarian carcinomas. Cancer Lett 162:105-115, 2001.




  1. Benoit BO, Savarese T, Joly M, Engstrom CM, Pang L, Reilly J, Recht LD, Ross AH, Quesenberry PJ: Neurotrophin channeling of neural progenitor cell differentiation. J Neurobiol 46(4):265-280, 2001.




  1. Quesenberry PJ, Zhong S, Wang H, Stewart FM: Allogeneic chimerism with low-dose irradiation, antigen presensitization, and costimulator blockade in H-2 mismatched mice. Blood 97(2):557-564, 2001.




  1. Frimberger AE, McAuliffe CI, Werme KA, Tuft RA, Fogarty KE, Benoit BO, Dooner MS, Quesenberry PJ: The Fleet Feet of Haematopoietic Stem Cells: Rapid Motility, Interaction and Proteopdia. Br J Haematol 112(3):644-654, 2001.

  1. Yüklə 413 Kb.

    Dostları ilə paylaş:
  1   2   3   4   5   6



Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©genderi.org 2024
rəhbərliyinə müraciət
    Ana səhifə
Psixologiya